ABILIFY Now Available for Younger Patients with Bipolar Disorder
March 3, 2008 by MedHeadlines
Filed under Bipolar Disorder, Children's Health, Drugs, FDA, Prevention
Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company have announced that a new drug for treatment of bipolar disorder in children and adolescents is now available. ABILIFY (aripiprazole) has been approved by the FDA for patients 10 to 17 years old for the treatment of acute manic and mixed episodes of Bipolar I Disorder, with or without psychotic features. Read more
Loading ...
